Vertex Sinks On Below-Consensus Revenue, Limited Sales From New Launches

Next Launches In Late 2026 Or Beyond

 
• By Mandy Jackson
  
Vertex's two new launches missed Q1 analyst targets (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Scrip